| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $807.8M | +35.7% |
| Cost of Revenue | $1.73B | -10.6% |
| R&D Expense | $1.18B | +25.6% |
| SG&A Expense | $901.0M | +13.0% |
| Operating Income | -$3.02B | +2.5% |
| Pre-tax Income | -$2.71B | +4.1% |
| Income Tax | $1.2M | +16.9% |
| Net Income | -$2.71B | +4.0% |
| EPS (Basic) | -$1.25 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.61B | +17.3% |
| Short-term Investments | $2.42B | -2.6% |
| Accounts Receivable | $112.0M | +116.2% |
| Inventory | $407.8M | -41.4% |
| Current Assets | $4.87B | +2.5% |
| Total Assets | $9.65B | +13.3% |
| Current Liabilities | $1.17B | +15.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.02B | +18.9% |
| Capital Expenditures | $883.8M | -2.9% |
| Investing Cash Flow | -$1.29B | -36.7% |
| Financing Cash Flow | $3.55B | +15.6% |
| Free Cash Flow | -$2.90B | +14.6% |
| +8.1% |
| EPS (Diluted) | -$1.25 | +8.1% |
| Long-term Debt |
| $2.00B |
| +0.3% |
| Total Liabilities | $4.48B | +22.2% |
| Stockholders' Equity | $3.87B | -20.2% |